Joint WHO/UNAIDS annual consultation with pharmaceutical companies: Global forecasts of antiretroviral demand 2012-2015
Dates: 5 - 6 November 2012
Place: Geneva, Switzerland
The main objectives of the meeting were to present and discuss global forecasts of antiretroviral demand in the next three years, and brief the pharmaceutical organizations on key HIV developments in WHO, UNAIDS and other partner organizations.
Documents
Presentations
Day 1
-
Towards Universal Access: progress and challenges
pdf, 1.84Mb -
Advancing Treatment 2.0: Progress on the 2013 consolidated guidelines - what's new
pdf, 3.56Mb -
D4T phase out
pdf, 502kb -
Joint WJP/UNAIDS annual consultation with pharmaceutical companies and stakeholders on global forecasts of antiretroviral demand 2012 – 2015
pdf, 234kb -
Global forecasts of antiretroviral demand 2013 - 2015
pdf, 388kb -
ARV access and challenges in Europe
pdf, 899kb -
WHO Survey on ARV and Diagnostic Use 2012: preliminary results
pdf, 463kb -
ARV sale trends in GPRM 2006-2012
pdf, 383kb -
Forecasting Demand for ARVs 2012 – 2015 Preliminary Analysis
pdf, 486kb -
Ensuring comprehensive care and treatment for people living with HIV/AIDS
pdf, 647kb -
Local solutions to ARV access
pdf, 456kb -
Financing ART in low- and middle-income countries
pdf, 1.74Mb -
Financial Resources for HIV: PEPFAR’s Contributions to the Global Scale-up of Treatment
pdf, 1.80Mb -
Global Fund investments in HIV
pdf, 430kb